Wolverine Trading
SUPN icon

Wolverine Trading’s Supernus Pharmaceuticals SUPN Stock Holding History

Wolverine Trading’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,000
Closed -$421K – 5675
2022
Q1 		$421K Buy
13,000
+3,100
+31% +$95K ﹤0.01% 3460
2021
Q4 		$297K Buy
+9,900
New +$300K ﹤0.01% 4170
2021
Q2 		– Sell
-7,900
Closed -$207K – 6672
2021
Q1 		$207K Buy
+7,900
New +$221K ﹤0.01% 5014
2020
Q2 		– Sell
-17,900
Closed -$307K – 5213
2020
Q1 		$307K Sell
17,900
-17,400
-49% -$366K ﹤0.01% 3189
2019
Q4 		$824K Sell
35,300
-4,600
-12% -$112K ﹤0.01% 2596
2019
Q3 		$1.1M Sell
39,900
-1,000
-2% -$29.6K ﹤0.01% 1893
2019
Q2 		$1.35M Sell
40,900
-39,500
-49% -$1.35M ﹤0.01% 1797
2019
Q1 		$2.82M Buy
80,400
+25,100
+45% +$934K 0.01% 1261
2018
Q4 		$1.79M Buy
55,300
+9,500
+21% +$409K 0.01% 1510
2018
Q3 		$2.31M Buy
45,800
+26,600
+139% +$1.31M 0.01% 1544
2018
Q2 		$879K Hold
19,200
– – ﹤0.01% 2402
2018
Q1 		$879K Buy
+19,200
New +$801K ﹤0.01% 2402
2017
Q3 		– Sell
-28,700
Closed -$1.23M – 5003
2017
Q2 		$1.23M Sell
28,700
-8,700
-23% -$310K 0.01% 1574
2017
Q1 		$1.17M Buy
37,400
+11,800
+46% +$316K 0.01% 1600
2016
Q4 		$646K Sell
25,600
-600
-2% -$13.4K ﹤0.01% 2326
2016
Q3 		$645K Sell
26,200
-7,900
-23% -$179K ﹤0.01% 2322
2016
Q2 		$677K Buy
+34,100
New +$605K ﹤0.01% 1940

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's SUPN Position: Q2 2021 in Review

Wolverine Trading sold out of Supernus Pharmaceuticals (SUPN) in Q2 2021, closing a stake of 7,641 shares — an estimated $234K sold.

Wolverine Trading first reported a position in SUPN in Q2 2016 and held it in 8 quarters. The position peaked at $737K in Q4 2018. 226 funds tracked by Wall St. Rank hold SUPN as of Q2 2021.

  • Wolverine Trading reported no remaining Supernus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Wolverine Trading sold 7,641 Supernus Pharmaceuticals shares in Q2 2021, an estimated $234K.
  • Wolverine Trading first reported a position in Supernus Pharmaceuticals in Q2 2016 and held it in 8 quarters.
  • Wolverine Trading's Supernus Pharmaceuticals position peaked at $737K in Q4 2018.
  • 226 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.